Queens, NY 的 三陰性乳癌 臨床試驗
15 項針對 三陰性乳癌 的研究正在 Queens（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- START New York Long Island LLC, Lake Success · 距離 9 英里
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
招募中1 期
- NYU Langone Hospital - Long Island, Mineola · 距離 11 英里
Study of AVZO-021 in Patients With Advanced Solid Tumors
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Mineola · 距離 11 英里
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
招募中3 期
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073), Mineola · 距離 11 英里
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
招募中3 期
- Clinical Research Alliance ( Site 0086), Westbury · 距離 14 英里
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
招募中1 期
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 距離 10 英里
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
招募中2 期
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 距離 13 英里
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
招募中3 期
- Northwell Health, Lake Success · 距離 9 英里
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
招募中1 期
- NYU Langone Health - Long Island, Mineola · 距離 11 英里
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
招募中2 期
- Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale · 距離 13 英里
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
招募中2/3 期
- Clinical Research Alliance, Westbury · 距離 14 英里
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- START New York Long Island, LLC, Lake Success · 距離 9 英里
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
招募中2 期
- Memorial Sloan Kettering Nassau, Uniondale · 距離 13 英里
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
招募中2 期
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 距離 13 英里
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
招募中2 期
- Clinical Research Alliance, Westbury · 距離 14 英里
其他城市的 三陰性乳癌 試驗
- Houston, TX42 項研究
- New York City, NY31 項研究
- Nashville, TN28 項研究
- Los Angeles, CA27 項研究
- Boston, MA26 項研究
- San Antonio, TX23 項研究
- St. Louis, MO21 項研究
- Arlington, VA20 項研究
- Atlanta, GA20 項研究
- Dallas, TX18 項研究
- Chicago, IL16 項研究
- Columbus, OH16 項研究
Queens 的其他研究
- 乳癌64 項研究
- 非小細胞肺癌49 項研究
- 大腸直腸癌31 項研究
- 轉移性癌症28 項研究
- 卵巢癌28 項研究
- 前列腺癌27 項研究
- 癌症（所有類型）26 項研究
- 子宮內膜癌25 項研究
- 肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤20 項研究
- 胰臟癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。